Chaparral Labs
back to publications

Publication

Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers.

Herman Mathieu, Randall Grace W, Spiegel Julia L, Maldonado Delphina J, Simoes Sabrina

Philosophical transactions of the Royal Society of London. Series B, Biological sciences2024DOI: 10.1098/rstb.2022.0387PMID 38368936
disease:ad

Abstract

Over the past two decades, increased research has highlighted the connection between endosomal trafficking defects and neurodegeneration. The endo-lysosomal network is an important, complex cellular system specialized in the transport of proteins, lipids, and other metabolites, essential for cell homeostasis. Disruption of this pathway is linked to a wide range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and frontotemporal dementia. Furthermore, there is strong evidence that defects in this pathway create opportunities for diagnostic and therapeutic intervention. In this

MeSH Terms

HumansNeurodegenerative DiseasesExosomesAlzheimer DiseaseLysosomesBiomarkers